Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/20560971

Download in:

View as

General Info

PMID
20560971